OncoTracker Expands Multiple Myeloma Intellectual Property

WEST HOLLYWOOD, Calif., March 12, 2019 /PRNewswire/ — OncoTracker, Inc. announced that it has strengthened its intellectual property portfolio in multiple myeloma by completing an agreement with the Institute for Myeloma and Bone Cancer Research to acquire worldwide rights to its intellectual property regarding both diagnostic testing and a new therapeutic approach for treating these patients.…